clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogreelibesilata - peripheral vascular diseases; stroke; myocardial infarction - antitromboottiset aineet - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segmentin nousua akuutti sydäninfarkti, yhdessä asa lääketieteellisesti hoitoa saaneilla potilailla oikeutettu liuotushoito. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. lisätietoja, katso kohta 5.
deca-durabolin 50 mg/ml injektioneste, liuos
aspen pharma trading limited - nandrolone decanoate - injektioneste, liuos - 50 mg/ml - nandroloni
emla lääkelaastari
aspen pharma trading limited - prilocaine, lidocaine - lääkelaastari - yhdistelmävalmisteet
gracial tabletti
aspen pharma trading limited - desogestrelum,ethinylestradiolum - tabletti - desogestreeli ja etinyyliestradioli
naropin 2 mg/ml injektio-/infuusioneste, liuos
aspen pharma trading limited - ropivacaini hydrochloridum - injektio-/infuusioneste, liuos - 2 mg/ml - ropivakaiini
naropin 7.5 mg/ml injektioneste, liuos
aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 7.5 mg/ml - ropivakaiini
naropin 10 mg/ml injektioneste, liuos
aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 10 mg/ml - ropivakaiini
naropin 5 mg/ml injektioneste, liuos
aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 5 mg/ml - ropivakaiini
ciprofloxacin hospira 2 mg/ml infuusioneste, liuos
hospira uk limited - ciprofloxacinum - infuusioneste, liuos - 2 mg/ml - siprofloksasiini
bosentan amneal 62.5 mg tabletti, kalvopäällysteinen
amneal pharma europe limited - bosentanum monohydricum - tabletti, kalvopäällysteinen - 62.5 mg - bosentaani